SCHEMBL4603254

SCHEMBL4603254

CCOc1ccc(-c2ccc(OC)c(OC)c2)cc1C(=O)O

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.59
KDM4E B2RXH2 3/20 0.56
SMN1; SMN2 Q16637 3/20 0.56
HSD17B10 Q99714 3/20 0.56
MEN1 O00255 2/20 0.56
KMT2A Q03164 2/20 0.56
MAPK1 P28482 2/20 0.54
ALDH1A1 P00352 2/20 0.52
APAF1 O14727 1/20 0.52
RECQL P46063 1/20 0.52
CASP6 P55212 1/20 0.52
CACNA1B Q00975 1/20 0.52
APBA1 Q02410 1/20 0.52
MCL1 Q07820 1/20 0.52
CASP8 Q14790 1/20 0.52
NPC1 O15118 1/20 0.52
RAB9A P51151 1/20 0.52
PTPN11 Q06124 4/20 0.52
CFD P00746 1/20 0.51
PTPN1 P18031 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2771810 0.91 CFD (0.61) TSHRKDM4EHSD17B10MEN1KMT2A
SCHEMBL4603132 0.90 NEK2 (0.56) TSHRKDM4ESMN1; SMN2HSD17B10MEN1
SCHEMBL4600533 0.89 TSHR (0.50) TSHRKDM4ESMN1; SMN2HSD17B10MEN1
SCHEMBL5154648 0.88 PTPN11 (0.60) KDM4ESMN1; SMN2HSD17B10MEN1KMT2A
SCHEMBL4600656 0.87 CFD (0.61) TSHRKDM4ESMN1; SMN2HSD17B10MAPK1
SCHEMBL5154645 0.87 TSHR (0.51) TSHRKDM4EHSD17B10MAPK1APAF1
SCHEMBL4600782 0.87 PTPN11 (0.54) TSHRKDM4ESMN1; SMN2HSD17B10MEN1
SCHEMBL4602660 0.85 TSHR (0.47) TSHRKDM4ESMN1; SMN2HSD17B10MEN1
SCHEMBL4603368 0.84 PTPN11 (0.59) TSHRHSD17B10KMT2AALDH1A1MCL1
SCHEMBL4602041 0.83 PTPN11 (0.57) TSHRHSD17B10KMT2AMCL1PTPN11

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1912970-A2 ACYLTRYPTOPHANOLS FOR FERTILITY CONTROL Bayer Schering Pharma Aktiengesellschaft (DE) 2008-04-23 EP claimed
US-20070060573-A1 Acyltryptophanols BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2007-03-15 US claimed
WO-2007017289-A2 ACYLTRYPTOPHANOLS FOR FERTILITY CONTROL BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2007-02-15 WO claimed
US-20070060573-A1 Acyltryptophanols BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2007-03-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070060573-A1 Acyltryptophanols FSHR, NPY1R, NPY2R TSHR 122/4885KDM4E 2399/4885SMN1; SMN2 3867/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.